Crystagen
- Category
- Bioregulators
- Administration routes
- Oral
- Regulatory status
- Not FDA-approved
What it is
Crystagen is a synthetic tripeptide (Glu-Asp-Pro) marketed to normalize immune function, boost stress resistance, and support thymus activity during aging. The case is mechanism only: effects on T-cell gene expression are unconfirmed in humans, so claimed benefits remain speculative. Independent safety data are limited, with a theoretical risk of worsening autoimmune conditions. It is not FDA-approved and circulates as unregulated research-grade product.
Read Full recordStudied uses & evidence
Studied uses(3)
Immune system normalization and support
SpeculativeDeveloper reports include laboratory studies and a small clinical comparison; independent clinical benefit remains unconfirmed.
Increased stress resistance in athletes
SpeculativeDeveloper reports describe combination use in athletes; they do not establish a Crystagen-specific benefit.
Support for thymus function during aging (immunosenescence)
SpeculativeDeveloper patent experiments include thymus models; clinical thymus rejuvenation remains unproven.
Evidence limits
- Evidence Level
- Very Limited Evidence
Direct clinical evidence for Crystagen is very limited. The strongest supporting data comes from the broader thymus peptide research (thymalin, thymogen) conducted in Russia over several decades, which shows immunocorrective effects. Crystagen specifically has been used in multi-peptide regimens for athletes but lacks standalone randomized controlled trials. The PMC-indexed thymalin review provides mechanistic context but not direct Crystagen clinical evidence.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(2)
Risks = level of concern: High · Moderate · Low · Theoretical
Limited independent safety data
HighPotential immune modulation in autoimmune conditions
Theoretical
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.